SIPHAT was created in 1989 within the framework of the restructuring of the (Central Pharmacy of Tunisia). Since then, driven by the idea of progress, it made the health issue – issue of the future – into the field where its accumulated successes keep it at leadership level.
In partnership with several foreign laboratories (Abbott, Bayer, Sanofi,…) and in permanent collaboration with other Tunisian pharmaceutical industries, SIPHAT is at the service of health. Its priority is to meet the needs of its customers and partners and to propose highly performing health care quality.
Assets: 9,000,000 dinars
Quotation on the Stock Exchange: as of May 2001
Allotment of shares :
1,800,000 shares of a nominal value of 5 dinars each, allocated as follows :
SIPHAT is set up in the southern suburbs of Tunis, at 20 minutes from the down town and at 30 minutes from the Tunis Carthage airport.
Adresse : Fondouk Choucha, 2013 Ben Arous, Tunisia.
We produce drugs of various galenic formulations :
Pasty forms |
Liquid forms |
Dry forms |
Suppositories Gels Ointments Creams |
Drinkable solutions and solutions for external use Injectable solutions Perfusable solutions |
Tablets Capsules Sachets |
CARDIOLOGIE AND ANGIOLOGIE | ||